What Is GLP-1? The Hormone, the Medicines, the Basics

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This guide lives in the PlexusDx Education Hub, where we unpack GLP-1 science, weight-management protocols, and the genetic factors behind metabolic decisions. Open the Education Hub

The short answer

The phrase "what is GLP-1" bundles together several related questions: what the medications are, how they act, what they treat, what side effects to expect, and what they cost. This overview answers each briefly and points you toward more focused reading. As of April 2026, GLP-1 receptor agonists are a class of compounds that engage the GLP-1 receptor to modulate glucose regulation, appetite, and satiety. Open the Education Hub for deeper dives.

How the mechanism works

GLP-1 receptor agonists act at the GLP-1 receptor in the pancreas, the hypothalamus, and the gastrointestinal tract. The result is slower gastric emptying, blunted post-meal glucose spikes, reduced appetite, and stronger satiety signaling. GIP/GLP-1 dual agonists such as tirzepatide add engagement of the GIP receptor, layering on a second incretin mechanism. Depending on the compound, dosing is weekly or daily, which delivers sustained receptor engagement over time.

What these medicines are approved to do

FDA-approved indications across the class include type 2 diabetes for most compounds, chronic weight management for Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and obstructive sleep apnea in adults with obesity for Zepbound, added in 2024. A key nuance: prescribing follows the specific brand's FDA-approved indication, and the same molecule under a different brand is not automatically interchangeable for insurance or coverage purposes.

Side effects worth knowing

The most commonly reported effects are gastrointestinal, including nausea, vomiting, diarrhea, and constipation, and they are typically most pronounced during dose titration. Every FDA-approved GLP-1 compound carries the class boxed warning for thyroid C-cell tumor risk observed in rodent studies. Rare but serious events include pancreatitis, gallbladder disease, and acute kidney injury in the setting of dehydration. Because tolerability differs so widely, the side-effect experience is one of the main reasons dosing and pacing are handled individually by a prescribing provider rather than set by a fixed rule.

What they cost and how access works

Manufacturer list prices for FDA-approved branded products typically run $800 to $1,600 per month at U.S. list as of April 2026. Your actual out-of-pocket cost depends on insurance coverage, the FDA indication written on the prescription, manufacturer savings card eligibility, and whether a compounded alternative is available through a licensed 503A pharmacy pathway.

Why the same molecule differs by brand

One point trips up many readers: a single active ingredient can appear under several brand names, yet those brands are not automatically interchangeable. Prescribing matches the specific brand's FDA-approved indication, so a product approved for type 2 diabetes is not the same, for insurance or coverage purposes, as a product approved for chronic weight management, even when the underlying molecule is identical. This is why coverage decisions, eligibility, and prior authorization can look so different from one brand to the next. It also explains why your prescribing provider chooses a particular brand deliberately rather than treating them as swappable. When you compare options or read cost figures online, keep the indication attached to each brand in mind, because that detail, more than the molecule alone, often determines what you can access and what you will pay.

The genetic layer beneath every GLP-1 decision

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as injection and oral options. What distinguishes the approach is upstream context. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline appetite regulation and energy balance. It does not predict response to any medication; it turns guesswork into an informed conversation with your provider.

Frequently Asked Questions

What are GLP-1 receptor agonists in one sentence?

They are a class of medications, FDA-approved for indications such as type 2 diabetes, chronic weight management, and, for Zepbound, obstructive sleep apnea, that engage the GLP-1 pathway to influence appetite, satiety, and glucose regulation. Each product is administered according to its own label and approved indication.

How quickly do they act in the body?

These medicines engage the GLP-1 receptor, and for tirzepatide the GIP receptor, to slow gastric emptying, blunt post-meal glucose, reduce appetite, and raise satiety signaling. Weekly dosing sustains receptor engagement. Effects on weight and A1C differ by compound and dose according to clinical trial data, so individual experiences vary.

Are all GLP-1 products approved for weight loss?

No. Approvals are product-specific. Some GLP-1 products are approved for type 2 diabetes, others for chronic weight management, and Zepbound is additionally approved for obstructive sleep apnea in adults with obesity. Your prescribing provider matches a specific brand to the indication that fits your clinical situation.

Can genetics tell me which GLP-1 to take?

No. The Precision Peptide Genetic Test does not predict response to GLP-1 receptor agonists or any specific medication. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline energy-balance biology, offering upstream context that applies across every compound in the class.

Keep reading across the PlexusDx Education Hub for more evidence-based GLP-1 and metabolic health explainers. Return to the Education Hub

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.